Back in 2010, about 130 different brands — notably Lipitor, Viagra, and Zoloft — accounted for 34% of the global pharma industry's total sales. But in the following years, during which many of those drugs fell off the patent cliff, the industry has changed in numerous ways. Here are a few ways pharma and healthcare companies have shifted their strategies.
